Eastman Chemical (EMN) Aperçu de l'action
Eastman Chemical Company est une entreprise de matériaux de spécialité présente aux États-Unis, en Chine et dans le monde entier. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 5/6 |
| Croissance future | 1/6 |
| Performances passées | 2/6 |
| Santé financière | 2/6 |
| Dividendes | 5/6 |
Récompenses
Analyse des risques
EMN Community Fair Values
Create NarrativeSee what 47 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
US$67.68
FV
9.5% surévalué décote intrinsèque9.52%
Revenue growth p.a.
53
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Eastman Chemical Company Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$74.12 |
| Plus haut sur 52 semaines | US$83.47 |
| Plus bas sur 52 semaines | US$56.11 |
| Bêta | 1.06 |
| Variation sur 1 mois | 2.94% |
| Variation sur 3 mois | -3.20% |
| Variation sur 1 an | -7.97% |
| Variation sur 3 ans | -8.84% |
| Variation sur 5 ans | -40.89% |
| Évolution depuis l'introduction en bourse | 227.60% |
Nouvelles et mises à jour récentes
Article d’analyse • May 09
Eastman Chemical's (NYSE:EMN) Soft Earnings Don't Show The Whole Picture
Eastman Chemical Company's ( NYSE:EMN ) stock was strong despite it releasing a soft earnings report last week. We...Seeking Alpha • May 04
Eastman Chemical: An Iran War Beneficiary
Summary Eastman Chemical remains a 'Buy,' benefiting from Middle East supply disruptions that are tightening markets and supporting price increases, especially in Chemical Intermediates. EMN expects Q2 EPS of $1.70–$1.90 and full-year EPS above $6, with free cash flow supporting a 4.3% dividend yield and $150 million in buybacks. Segment performance is mixed: Advanced Materials faces margin pressure, Additives & Functional sees stable growth, while Fibers is hit by tariffs and Middle East exposure. I target $6.25–$6.75 in 2024 EPS and a 12x multiple ($84 PT), with upside driven by sustained supply constraints and resilient end-market demand. Read the full article on Seeking Alpha
Mise à jour du récit • May 02
EMN: Supply Tightness And EV Glass Demand Will Support Earnings Recovery Potential
Analysts have made a modest upward adjustment to the Eastman Chemical price target to $96.01 from $95.39, reflecting updated views on the company following a mix of recent target hikes and one slight trim across major research firms. Analyst Commentary Recent Street research around Eastman Chemical has been active, with a cluster of price target changes and at least one upgrade, alongside a single modest trim.Recent updates
Article d’analyse • May 09
Eastman Chemical's (NYSE:EMN) Soft Earnings Don't Show The Whole Picture
Eastman Chemical Company's ( NYSE:EMN ) stock was strong despite it releasing a soft earnings report last week. We...Seeking Alpha • May 04
Eastman Chemical: An Iran War Beneficiary
Summary Eastman Chemical remains a 'Buy,' benefiting from Middle East supply disruptions that are tightening markets and supporting price increases, especially in Chemical Intermediates. EMN expects Q2 EPS of $1.70–$1.90 and full-year EPS above $6, with free cash flow supporting a 4.3% dividend yield and $150 million in buybacks. Segment performance is mixed: Advanced Materials faces margin pressure, Additives & Functional sees stable growth, while Fibers is hit by tariffs and Middle East exposure. I target $6.25–$6.75 in 2024 EPS and a 12x multiple ($84 PT), with upside driven by sustained supply constraints and resilient end-market demand. Read the full article on Seeking AlphaMise à jour du récit • May 02
EMN: Supply Tightness And EV Glass Demand Will Support Earnings Recovery Potential
Analysts have made a modest upward adjustment to the Eastman Chemical price target to $96.01 from $95.39, reflecting updated views on the company following a mix of recent target hikes and one slight trim across major research firms. Analyst Commentary Recent Street research around Eastman Chemical has been active, with a cluster of price target changes and at least one upgrade, alongside a single modest trim.Mise à jour du récit • Apr 18
EMN: Supply Tightness And Completed Buybacks Will Support Earnings Recovery Potential
Analysts have modestly raised their fair value estimate for Eastman Chemical to $95.39. This reflects updated price targets and recent research that points to slightly stronger revenue growth and profitability assumptions.
Mise à jour du récit • Apr 04
EMN: Future Earnings Recovery Will Struggle With Persistent Commodity Oversupply
Analyst price targets for Eastman Chemical have shifted higher by several dollars into the mid $70s to mid $80s range, as analysts factor in updated commodity chemical forecasts, evolving geopolitical supply constraints, and a slightly adjusted risk profile reflected in modest tweaks to discount rate, revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Street research on Eastman Chemical over recent months has featured a mix of higher price targets and recalibrated views on risk, as firms respond to commodity market forecasts, geopolitical bottlenecks in key shipping routes, and sector wide concerns around capacity and demand.Mise à jour du récit • Mar 20
EMN: Supply Disruptions And Cash Returns Will Support Earnings Recovery Potential
Analysts nudged the fair value estimate for Eastman Chemical higher from $90.83 to $92.24, citing updated commodity chemical forecasts tied to supply disruptions and refined assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Eastman Chemical has leaned constructive, with several bullish analysts updating price targets and assumptions in response to both company specific factors and shifts in commodity markets.Mise à jour du récit • Mar 05
EMN: Modest Upside As Oversupply And Deindustrialization Restrain Earnings Recovery Potential
Analysts have lifted their average price targets on Eastman Chemical by a mid single digit dollar range, with moves such as Evercore ISI taking its target to $75 from $70, as they factor in slightly different views on long term growth, profitability and valuation multiples, reflected in modest adjustments to revenue growth, profit margin, discount rate and future P/E assumptions. Analyst Commentary While several firms have nudged price targets higher on Eastman Chemical, there is also a thread of caution running through recent research that is worth keeping in mind when you think about risk and reward.Mise à jour du récit • Feb 19
EMN: Cost Actions And Cash Returns Will Support Earnings Recovery Potential
Analysts have nudged their fair value estimate for Eastman Chemical up by about $1 to $90.83, pointing to refreshed assumptions around modestly positive revenue growth, a slightly lower discount rate, and a marginally reduced future P/E multiple as key drivers behind recent price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of upward price target revisions for Eastman Chemical, even as some firms fine tune assumptions to reflect mixed end markets.Mise à jour du récit • Feb 04
EMN: Oversupplied Commodity Markets Will Constrain Future Earnings Recovery Potential
Analysts have raised their fair value estimate for Eastman Chemical from $60.00 to $67.00. This reflects updated assumptions for revenue growth, profit margins, and a higher future P/E multiple, following a series of recent price target increases across the Street.Mise à jour du récit • Jan 21
EMN: Cost Savings And Free Cash Flow Will Support Earnings Recovery Potential
Narrative Update Analysts have trimmed their consolidated price expectations for Eastman Chemical by around $1. They are factoring in softer revenue growth assumptions, slightly lower future P/E multiples, and a mixed set of recent target changes that balance cautious industry views with confidence in cash generation and margin resilience.Mise à jour du récit • Jan 07
EMN: Cost Savings And Asset Utilization Will Drive Earnings Recovery Potential
Analysts have trimmed their fair value estimate for Eastman Chemical to about $90 from roughly $95, reflecting slightly higher discount rate assumptions and somewhat softer profit margin expectations. They still point to cost savings, asset utilization ramps and solid free cash flow as key supports for their updated price targets around $73 to $75.Article d’analyse • Jan 05
These 4 Measures Indicate That Eastman Chemical (NYSE:EMN) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Mise à jour du récit • Dec 23
EMN: Cost Savings And Asset Utilization Will Support Stronger Free Cash Flow
Analysts have nudged their average price target for Eastman Chemical slightly higher to about $73 from roughly $72.75, citing expectations for 2026 earnings tailwinds from cost savings, improved asset utilization, and resilient free cash flow even through a sluggish demand backdrop. Analyst Commentary Bullish analysts highlight that, despite modest adjustments to price targets, the long term investment case for Eastman Chemical remains underpinned by 2026 earnings tailwinds, including structural cost savings and improved asset utilization that are expected to drive margin expansion and profit growth from 2025 onward.Mise à jour du récit • Dec 09
EMN: Cost Savings And Asset Utilization Will Drive Earnings Higher From 2025
Analysts have modestly trimmed their price target on Eastman Chemical by about $2 per share to approximately $74, citing a still challenging macro backdrop but highlighting improving 2026 earnings visibility driven by cost savings, asset utilization tailwinds, and the company’s ability to sustain solid free cash flow through the current earnings trough. Analyst Commentary Recent Street commentary reflects a generally constructive stance on Eastman Chemical, with price targets clustered in the low to mid 70s and Buy ratings maintained even as estimates and targets are adjusted to reflect a tougher macro environment.Mise à jour du récit • Nov 25
EMN: Cost Savings And Asset Utilization Will Drive Earnings From 2025
The average analyst price target for Eastman Chemical has edged slightly lower to approximately $73, down less than $1, as analysts cite both resilient free cash flow and ongoing cost-saving initiatives in the context of a mixed demand outlook. Analyst Commentary Recent analyst updates reflect a nuanced perspective on Eastman Chemical's outlook, with both bullish and bearish takeaways emerging from the latest price target revisions and research commentary.Mise à jour du récit • Nov 09
EMN: Cost Savings And Asset Utilization Will Drive Earnings Upside Ahead
Eastman Chemical's analyst price target was adjusted slightly downward by $1.53 to $73.06, as analysts cite a focus on cash generation and persistent end-market sluggishness, even though earnings improvements are expected ahead. Analyst Commentary Recent analyst updates on Eastman Chemical reflect a mix of cautious optimism and ongoing concerns related to the company's valuation and execution in a challenging market environment.Mise à jour du récit • Oct 26
Commodity End Markets And Recycling Initiatives Will Shape Recovery Prospects Ahead
Eastman Chemical's analyst price target has been reduced by approximately $1 to $74.59. Analysts cite persistent macro headwinds and weakening conditions in commodity and industrial end markets as key factors behind this revised outlook.Mise à jour du récit • Oct 12
Molecular Recycling And Specialty Materials Will Expand Global Reach
Analysts have lowered their price target for Eastman Chemical from $86 to $75, citing expectations of softer revenue growth and a moderately higher discount rate. Analyst Commentary Bullish Takeaways Bullish analysts continue to maintain a Buy rating on Eastman Chemical, citing confidence in the company's longer-term fundamentals.Article d’analyse • Aug 02
Eastman Chemical Company (NYSE:EMN) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Eastman Chemical Company ( NYSE:EMN ) shareholders that were waiting for something to happen have been dealt a blow...Article d’analyse • Jun 18
We Think Eastman Chemical (NYSE:EMN) Can Stay On Top Of Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Seeking Alpha • Jan 26
Following Up On A Correctly-Rated Eastman Chemical Company In 2025 (Rating Upgrade)
Summary Eastman Chemical has underperformed recently but shows promise with improved valuation and strategic direction, making it a conservative "Buy" for 2025. The company’s strong fundamentals, diverse product portfolio, and focus on sustainability, especially in molecular recycling, position it well for future growth. Despite recent declines, Eastman’s operational improvements, share buybacks, and favorable macro trends suggest significant upside potential, with expected earnings growth in the coming years. I rate Eastman Chemical a "Buy" at a valuation target of $140/share, anticipating a 15% annualized return based on a 12.2x P/E multiple. Read the full article on Seeking AlphaSeeking Alpha • Oct 14
Eastman Chemical: Difficult To See Upside At This Valuation (Rating Downgrade)
Summary Eastman Chemical Company has shown strong 2Q24 results, particularly in advanced materials, but its current valuation appears overvalued, leading to a “Hold” rating. The company's strategic focus on specialty products and de-commoditization, along with new assets, has improved margins and operational performance. Despite positive trends, macroeconomic pressures and weak underlying demand outside destocking pose challenges, with limited upside potential at the current valuation. Eastman Chemical remains a fundamentally sound and ESG-focused company, but better investment opportunities exist in the market, warranting caution. Read the full article on Seeking Alpha
Nouveau récit • Aug 22
Transforming Challenges Into Opportunities With Green Chemical Recycling And Innovative Growth
Expansion in sustainable solutions like chemical recycling and the Tritan product line indicates potential for revenue growth and market share increase.Seeking Alpha • Jul 10
Eastman Chemical Running In Place (Rating Downgrade)
Summary Eastman Chemical is a $11.1 billion market cap specialty chemicals company offering a 3.4% dividend. The company’s new focus is on molecular (plastic) recycling. It has just opened a plant in Tennessee and received a US government grant to build one in Texas. Eastman’s second-largest number of plants are in high-cost Europe (nine). However, it is geographically diversified with 16 US plants and several in Asia and Latin America. Read the full article on Seeking AlphaRendement pour les actionnaires
| EMN | US Chemicals | US Marché | |
|---|---|---|---|
| 7D | 3.5% | 0.5% | 1.1% |
| 1Y | -8.0% | 8.9% | 28.7% |
Rendement vs Industrie: EMN a sous-performé le secteur US Chemicals qui a rapporté 8.9 % au cours de l'année écoulée.
Rendement vs marché: EMN a sous-performé le marché US qui a rapporté 28.7 % au cours de l'année écoulée.
Volatilité des prix
| EMN volatility | |
|---|---|
| EMN Average Weekly Movement | 4.9% |
| Chemicals Industry Average Movement | 7.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Cours de l'action stable: EMN n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de EMN ( 5% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1920 | 13,000 | Mark Costa | www.eastman.com |
Eastman Chemical Company est une entreprise de matériaux spécialisés qui opère aux États-Unis, en Chine et dans le monde entier. Le segment Additifs et produits fonctionnels de la société propose des blocs de construction à base de dérivés d'amines, des intermédiaires pour les surfactants, des fumigants de sol à base de métam et des solutions à base d'acides organiques ; des coalescents et solvants spécialisés, des additifs pour peinture et des polymères spécialisés ; et des fluides de transfert de chaleur et d'aviation. Elle dessert les marchés des transports, des soins personnels, du bien-être, de l'alimentation humaine et animale, de l'agriculture, du bâtiment et de la construction, du traitement de l'eau, de l'énergie, des biens de consommation, des biens durables et de l'électronique.
Eastman Chemical Company Résumé des fondamentaux
| EMN statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$8.47b |
| Bénéfices(TTM) | US$399.00m |
| Recettes(TTM) | US$8.64b |
21.2x
Ratio P/E1.0x
Ratio P/SLe site EMN est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| EMN compte de résultat (TTM) | |
|---|---|
| Recettes | US$8.64b |
| Coût des recettes | US$6.93b |
| Marge brute | US$1.71b |
| Autres dépenses | US$1.31b |
| Les revenus | US$399.00m |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 3.49 |
| Marge brute | 19.83% |
| Marge bénéficiaire nette | 4.62% |
| Ratio dettes/capitaux propres | 89.6% |
Quelles ont été les performances à long terme de EMN?
Voir les performances historiques et les comparaisonsDividendes
4.5%
Rendement actuel des dividendes96%
Ratio de distributionLe site EMN verse-t-il des dividendes fiables ?
Voir EMN l'historique des dividendes et les indices de référence| Eastman Chemical dates des dividendes | |
|---|---|
| Date ex-dividende | Jun 15 2026 |
| Date de paiement du dividende | Jul 08 2026 |
| Jours jusqu'au dividende Ex | 21 days |
| Jours jusqu'à la date de paiement du dividende | 44 days |
Le site EMN verse-t-il des dividendes fiables ?
Voir EMN l'historique des dividendes et les indices de référenceAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/24 06:24 |
| Cours de l'action en fin de journée | 2026/05/22 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Eastman Chemical Company est couverte par 36 analystes. 13 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Sergey Vasnetsov | Barclays |
| Michael Leithead | Barclays |
| Paretosh Misra | Berenberg |